Boston Scientific Other, Other Long-term Assets decreased by 14.0% to $380.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.0%, from $400.00M to $380.00M. Over 4 years (FY 2020 to FY 2024), Other, Other Long-term Assets shows an upward trend with a 24.7% CAGR.
other_other_other_longterm_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $224.00M | $223.00M | $225.00M | $230.00M | $230.00M | $247.00M | $271.00M | $280.00M | $295.00M | $314.00M | $306.00M | $341.00M | $381.00M | $400.00M | $402.00M | $443.00M | $442.00M | $380.00M |
| QoQ Change | — | -0.4% | +0.9% | +2.2% | +0.0% | +7.4% | +9.7% | +3.3% | +5.4% | +6.4% | -2.5% | +11.4% | +11.7% | +5.0% | +0.5% | +10.2% | -0.2% | -14.0% |
| YoY Change | — | — | — | — | +2.7% | +10.8% | +20.4% | +21.7% | +28.3% | +27.1% | +12.9% | +21.8% | +29.2% | +27.4% | +31.4% | +29.9% | +16.0% | -5.0% |